Trials / Terminated
TerminatedNCT02462837
Myrbetriq™ (Mirabegron) to Reduce Pain and Discomfort Following Ureteral Stent Placement
- Status
- Terminated
- Phase
- Phase 2
- Study type
- Interventional
- Enrollment
- 11 (actual)
- Sponsor
- Southern Illinois University · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
The objective of this pilot study is to assess whether Myrbetriq™ will improve post-operative ureteral pain and discomfort, reduce bladder storage symptoms and increase quality of life following ureteral stenting.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Mirabegron | |
| DRUG | Placebo |
Timeline
- Start date
- 2015-05-01
- Primary completion
- 2019-01-30
- Completion
- 2019-01-30
- First posted
- 2015-06-04
- Last updated
- 2023-06-13
- Results posted
- 2023-06-13
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT02462837. Inclusion in this directory is not an endorsement.